Yanyun Wu

Apheresis for babesiosis: Therapeutic parasite reduction or removal of harmful toxins or both?

Preoperative management of factor XI deficiency with therapeutic plasma exchange: A case report and literature review.

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.

Use of hydroxyethyl starch in leukocytapheresis procedures does not increase renal toxicity.

Serological blind spots for variants of human IgG3 and IgG4 by a commonly used anti-immunoglobulin reagent.

Apheresis Medicine education in the United States of America: State of the discipline.

Hemostasis management and therapeutic plasma exchange: Results of a practice survey.

Hemostasis testing and therapeutic plasma exchange: Results of a practice survey.

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue.

Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommittee.

Hydroxocobalamin administration for treatment of vasoplegic syndrome associated with cardiopulmonary bypass causes red plasma.

Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA-associated vasculitis.

Effect of bedside filtration on aggregates from cold-stored whole blood-derived platelet-rich plasma and apheresis platelet concentrates.

Simultaneous multiparameter whole blood hemostasis assessment using a carbon nanotube-paper composite capacitance sensor.

Comprehensive multiparameter evaluation of platelet function using a highly sensitive membrane capacitance sensor.

Management of human leukocyte antigen-mediated platelet transfusion refractoriness: Brief synopsis and recent literature review.

A Descriptive 5-Year Analysis of the Demographics and Therapies for Patients With Immune Thrombotic Thrombocytopenic Purpura in the USA: A Multicenter Study of 390 Disease Episodes From 2017 to 2021.